Beshar Luke M
SEC-identified person · CIK 1192128 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Protara Therapeutics, Inc. TARA | Director | filed 2020–2026 |
| Omega Therapeutics, Inc. OMGA | Director | filed 2021–2023 |
| Trillium Therapeutics Inc. TRIL | Director | filed 2021–2021 |
| Regenxbio Inc. RGNX | Director | filed 2015–2021 |
| NPS Pharmaceuticals INC NSPS | SVP &CFO | filed 2007–2015 |
| Cambrex Corp DBM | Executive Vice President | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.